Skip to main content

Marta Torres Ferrús

Sóc Llicenciada en Medicina per la Universitat Autònoma de Barcelona. Em vaig especialitzar en Neurologia a l'Hospital Universitari Vall d'Hebron on continuo la meva activitat assistencial i investigadora a la Unitat de Cefalees del Servei de Neurologia.

Institutions of which they are part

Main researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca
Neurology
General Hospital

Marta Torres Ferrús

Institutions of which they are part

Main researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca
Neurology
General Hospital

Sóc Llicenciada en Medicina per la Universitat Autònoma de Barcelona. Em vaig especialitzar en Neurologia a l'Hospital Universitari Vall d'Hebron on continuo la meva activitat assistencial i investigadora a la Unitat de Cefalees del Servei de Neurologia.

Sóc membre de la "International Headache Society", Grup d'Estudi de Cefalees de la Societat Espanyola de Nerurologia (GECSEN) i de la Societat Catalana de Neurologia.
He rebut múltiples beques per a la realització de projectes de investigació. He publicat articles originals i de revisió i tinc experiència en la realització d'assajos clínics.

Projects

SAMBA: Análisis de biomarcadores de migraña en saliva

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 70785
Reference: PI16/01525
Duration: 01/01/2017 - 31/12/2020

Cefalea i dolor neurològic

IP: Patricia Pozo Rosich
Collaborators: Marta Torres Ferrús, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 45000
Reference: PM-CAIXA-2014-01
Duration: 07/01/2015 - 06/01/2017

Related news

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Related professionals

Torres Moreno, Maria del Carmen

Torres Moreno, Maria del Carmen

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Alberich Jordà, Manel

Alberich Jordà, Manel

Research technician
Neuroradiology
Read more
Navas Moya, Elisabeth

Navas Moya, Elisabeth

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Humet Diez, Anna

Humet Diez, Anna

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.